Wearable devices detect and predict inflammatory bowel disease flare-ups
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in ...
Healio53m
IBD drug market rattles as Lilly’s Omvoh nabs FDA approval for second IL-23p19 in Crohn’s
The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second interleukin-23p19 specific inhibitor approved for both major types of inflammatory ...